A CROSS-SECTIONAL STUDY OF THYROID DISORDER IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN A TERTIARY CARE HOSPITAL
DOI:
https://doi.org/10.22159/ajpcr.2022.v15i8.45000Keywords:
Type 2 diabetes mellitus, Hypothyroidism, Subclinical hypothyroidismAbstract
Objectives: The objectives of the study were to assess thyroid function in diabetes mellitus by estimating free T3, free T4, and TSH in type 2 diabetic subjects, and the correlation between TSH and HbA1c.
Methods: It was a cross-sectional study. The study was conducted at the Sapthagiri Institute of Medical Science in Bengaluru, Karnataka, and a total of 75 newly diagnosed type 2 diabetes mellitus patients were enrolled for this study from January 2020 to January 2021.
Results: The prevalence of thyroid disorder among type 2 diabetes mellitus patients was 14.7% (11). Out of 11 cases, 4 (5.4%) cases belonged to hypothyroidism, 1 (1.3%) case was hyperthyroidism, 6 (8.0%) cases were subclinical hypothyroidism, and subclinical hyperthyroidism cases were not found in this study. Normal thyroid function was found in 64 (85.3%) cases.
Conclusion: Thyroid disorders are more prevalent in people with type 2 diabetes. Female diabetics are more likely to have this finding. Subclinical hypothyroidism is the most frequent thyroid disorder. Thyroid disorders are more commonly associated with diabetes among people with diabetes who have poor metabolic control.
Downloads
References
Defronzo RA. From the triumvirate to the ominous octet: A new paradigm for the treatment of type 2 diabetes mellitus Diabetes. 2009;58:773-95. doi: 10.2337/db09-9028
Wright E Jr., Scism-Bacon JL, Glass LC. Oxidative stress in type 2 diabetes: The role of fasting and postprandial glycemia. Int J Clin Pract 2006;60:308-14.
Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-53. https://doi.org/10.2337/diacare.27.10.2568
Coller FA, Huggins CB. Effect of hyperthyroidism upon diabetes mellitus: Striking improvement in diabetes mellitus from thyroidectomy. Ann Surg 1927;86:877-84. doi: 10.1097/00000658-192712000-00009
Okajima F, Ui M. Metabolism of glucose in hyper-and hypo-thyroid rats in vivo. Glucose-turnover values and futile-cycle activities obtained with 14C-and 3H-labelled glucose. Biochem J 1979;182:565-75. https://doi.org/10.1042/bj1820565
Leong KS, Wallymahmed M, Wilding J, MacFarlane I. Clinical presentation of thyroid dysfunction and Addison’s disease in young adults with type 1 diabetes. Postgrad Med J 1999;75:467-70.
Miki N, Ono M, Iizuka N, Aoki T, Demura H. Thyroid hormone modulation of the hypothalamic growth hormone (GH)-releasing factor-pituitary GH axis in the rat. J Clin Investig 1992;90:113-20.
Cooper DS, Greenspan FS, Ladenson PN. The thyroid gland. In: Gardner DG, Shoback D, editors. Greenspan’s Basic and Clinical Endocrinology. New York: McGraw-Hill Medical; 2007. p. 209-280. PubMed: 11474665
Jameson JL, Mandel SJ, Weetman AP. Disorders of the thyroid gland. In: Longo DL, Fauci AS, Kasper DL, Hauser SL, Jameson JL, Localzo J, editors. Harrison’s Principles of Internal Medicine. New York: McGraw-Hill Medical; 2014. p. 2251-334.
Turner HE, Wass TA, editors. Thyroid. In: Oxford Handbook of Endocrinology and Diabetes. New York: Oxford University Press; 2010. p. 2-70.
Celani MF, Bonati ME, Stucco N. Prevalence of abnormal thyrotropin concentrations measured by a sensitive assay in patients with type 2 diabetes mellitus. Diabetes Res 1994;27:15-25.
Moghetti P, Castello R, Tosi F, Zenti MG, Magnani C, Bolner A, et al. Glucose counterregulatory response to acute hypoglycemia in hyperthyroid human subjects. J Clin Endocrinol Metab 1994;78:169-73. DOI: 10.1210/jcem.78.1.8288700
Udiong CE, Udoh AE, Etukudoh ME. Evaluation of thyroid function in diabetes mellitus in Calabar, Nigeria. Indian J Clin Biochem 2007;22:74-8. doi: 10.1007/BF02913318
Turner HE, Wass TA, editors. Diabetes. In: Oxford Handbook of Endocrinology and Diabetes. New York: Oxford University Press; 2010. p. 724-822.
Chinenye S, Uloko AE, Ogbera AO, Ofoegbu EN, Fasanmade OA, Fasanmade AA, et al. Profile of Nigerians with diabetes mellitus-diabcare Nigeria study group (2008): results of a multi-center study. Indian J Endocrinol Metab 2012;16:558-64. doi: 10.4103/2230- 8210.98011
Ofoegbu EN, Oli JM, Igwe JC. Body composition of Nigerian diabetics using Bioimpedance analysis (BIA). Niger Health Biomed Sci 2004;3:37-9. DOI: 10.4314/njhbs.v3i1.11505
Okafor CI, Ofoegbu EN. Control to the goal of cardiometabolic risk factors among Nigerians living with type 2 diabetes mellitus. Niger J Clin Pract 2012;15:15-8. DOI: 10.4103/1119-3077.94089
Telwani AA, Wani ZH, Ashraf Y, Shah AA. Prevalence of thyroid dysfunction in type 2 diabetes mellitus: A case-control study. Int J Res Med Sci 2017;5:4527-31. DOI: http://dx.doi.org/10.18203/2320-6012. ijrms20174590
Babu K, Kakar A, Byotra SP. Prevalence of thyroid disorder in type II diabetes mellitus patients. J Assoc Phys Ind 2001;49:43.
Udenze I, Nnaji I, Oshodi T. Thyroid function in adult Nigerians with metabolic syndrome. Pan Afr Med J 2014;18:352-4. PMCID: PMC4282811 DOI: 10.11604/pamj.2014.18.352.4551
Biondi B. Thyroid and obesity: An intriguing relationship. J Clin Endocrinol Metab 2010;95:3614-7. https://doi.org/10.1210/ jc.2010-1245
Lagradi G, Emerson CH, Ahima RS. Leptin prevents fasting-induced suppression of thyrotropin-releasing hormone messenger ribonucleic acid in neurons of the hypothalamic paraventricular nucleus. Endocrinology 1997;138:2569-76. DOI: 10.1210/endo.138.6.5209
Ogbonna SU, Ezeani IU. Risk factors of thyroid dysfunction in patients with type 2 diabetes mellitus. Front Endocrinol 2019;10:440. https:// doi.org/10.3389/fendo.2019.00440
Gursoy NT, Tuncel E. The relationship between the glycaemic control and hypothalamus-pituitary-thyroid axis in diabetic patients. Turk J Endocrinol Metab 1999;12:163-8.
Bazrafshan HR, Ramezani A, Salehi A, Shir AA, Mohammadian S, Faraj EM, et al. Thyroid dysfunction and its relationship with diabetes mellitus (NIDDM). J Gorgan Univ Med Sci 2000;2:5-11.
Ardekani MA, Rashidi M, Shojaoddiny A. Effect of thyroid dysfunction on metabolic response in type 2 diabetic patients. Iran J Diabetes Obesity 2010;2:20-6.
Schlienger JL, Monceau A, Chabrier G, North ML, Stephan F. Effect of diabetic control on the level of circulating thyroid hormones. Diabetologia 1982;22:486-8.
Velija-Asimi Z, Karamehic J. The effects of treatment of subclinical hypothyroidism on metabolic control and hyperinsulinemia. Med Arch 2007;61:20-1. PMID: 17582969
Published
How to Cite
Issue
Section
Copyright (c) 2022 Dr Ravi Shekhar
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
